Structure-immune response relationships of hapten-modified collagen II peptides in a T-cell model of allergic contact dermatitis

Chemical Research in Toxicology

Volumn 21, Issue 8, 2008, Pages 1514-1523

  Holmdahl, Meirav ^a,b   Ahlfors, Stefan R ^b   Holmdahl, Rikard ^b,c   Hansson, Christer ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c TURKU UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; 2,4 DINITROPHENOL; COLLAGEN TYPE 2; HAPTEN; LYSINE;

ARTICLE; CHEMICAL STRUCTURE; CROSS REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNE RESPONSE; IMMUNIZATION; PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE; RACEMIZATION; SKIN ALLERGY; STEREOCHEMISTRY; SYNTHESIS; T LYMPHOCYTE;

ANIMALS; COLLAGEN TYPE II; CROSS REACTIONS; DERMATITIS, ALLERGIC CONTACT; DINITROFLUOROBENZENE; HAPTENS; HYBRIDOMAS; IMMUNODOMINANT EPITOPES; LYSINE; MICE; MICE, TRANSGENIC; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES;

MUS;

EID: 51449118371     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx8001077     Document Type: Article

References (37)

1. Thyssen, J. P., Linneberg, A., Menne, T., and Johansen, J. D. (2007) The epidemiology of contact allergy in the general population - prevalence and main findings. Contact Derm. 57, 287-299.
2. Lepoittevin, J.-P. (2006) Molecular Aspects of Allergic Contact Dermatitis. In Contact Dermatitis, 4th ed. (Frosch, P. J., Menne, T., and Lepoittevin, J.-P., Eds.) pp 45-66, Springer, Berlin/Heidelberg.
3. Eisen, H. N. (2001) Specificity and degeneracy in antigen recognition: Yin and Yang in the immune system. Ann. Rev. Immun. 19, 1-21.
4. Smith, C. H., and Hotchkiss, S. A. M. (2001) Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms, Taylor and Francis, London/New York.
5. Watanabe, H., Unger, M., Tuvel, B., Wang, B., and Sauder, D. N. (2002) Contact hypersensitivity: The mechanism of immune responses and T cell balance. J. Interferon Cytokine Res. 22, 407-412.
6. O'Leary, J. G., Goodarzi, M., Drayton, D. L., and von Andrian, U. H. (2006) T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7, 507-516.
7. Kimber, I., and Dearman, R. J. (2002) Allergic contact dermatitis: The cellular effectors. Contact Derm. 46, 1-5.
8. Vocanson, M., Hennino, A., Cluzel-Tailhardat, M., Saint-Mezard, P., Benetiere, J., Chavagnac, C., Berard, F., Kaiserlian, D., and Nicolas, J.-F. (2006) CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J. Invest. Dermatol. 126, 815-820.
9. Gorbachev, A. V., and Fairchild, R., L. (2004) CD4+ T cells regulate CD8+ T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism. J. Immunol. 172, 2286-2295.
10. Cemerski, S., and Shaw, A. (2006) Immune synapses in T-cell activation. Curr. Opin. Immunol. 18, 298-304.
11. Rustemeyer, T., van Hoogstraten, I. M. W., von Blomberg, B. M. E., and Scheper, R. J. (2006) Mechanisms in Allergic Contact Dermatitis. In Contact Dermatitis, 4th ed. (Frosch, P. J., Menne, T., and Lepoittevin, J.-P., Eds.) pp 11-33, Springer, Berlin/Heidelberg.
12. Pickard, C., Smith, A. M., Hywel, C., Strickland, I., Jackson, J., Healy, E., and Friedmann, P. S. (2006) Investigation of mechanisms underlying the T-cell response to the hapten 2,4-dinitrochlorobenzene. J. Invest. Dermatol. 137, 630-637.
13. Wang, B., Fujisawa, H., Zhuang, L., Freed, I., Howell, B. G., Shahid, S., Shivji, G. M., Mak, T. W., and Sauder, D. N. (2000) CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165, 6783-6790.
14. Bäcklund, J., Carlsen, S., Höger, T., Holm, B., Fugger, L., Kihlberg, J., Burkhardt, H. L., and Holmdahl, R. (2002) Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 99, 9960-9965.
15. Rosloniec, E. F., Brand, D. D., Myers, L. K., Esaki, Y., Whittington, K. B., Zaller, D. M., Woods, A., Stuart, J. M., and Kang, A. H. (1998) Induction of autoimmune arthritis in HLA-DR4 (DRB1* 0401) transgenic mice by immunization with human and bovine type II collagen. J. Immunol. 160, 2573-2578.
16. Michaelsson, E., Andersson, M., Engström, A., and Holmdahl, R. (1992) Identification of an immunodominant type-II collagen peptide recognized by T-cells in H-2q mice: Self tolerance at the level of determinant selection. Eur. J. Immunol. 22 1819-1825.
17. Michaelsson, E., Malmstrom, V., Reis, S., Engström, A., Burkhardt, H., and Holmdahl, R. (1994) T-Cell recognition of carbohydrates on type-II collagen. J. Exp. Med. 180, 745-749.
18. Michaelsson, E., Broddefalk, J., Engström, A., Kihlberg, J., and Holmdahl, R. (1996) Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells. Eur. J. Immunol. 26, 1906-1910.
19. Corthay, A., Backlund, J., Broddefalk, J., Michaelsson, E., Goldschmidt, T. J., Kihlberg, J., and Holmdahl, R. (1998) Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur. J. Immunol. 28, 2580-2590.
20. Kjellen, P., Brunsberg, U., Broddefalk, J., Hansen, B., Vestberg, M., Ivarsson, I., Engstrom, A., Svejgaard, A., Kihlberg, J., Fugger, L., and Holmdahl, R. (1998) The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2A(q) and H-2A(p) molecules. Eur. J. Immunol. 28, 755-767.
21. Andersson, E. C., Hansen, B. E., Jacobsen, H., Madsen, L. S., Andersen, C. B., Engberg, J., Rothbard, J. B., Sonderstrup McDevitt, G., Malmstrom, V., Holmdahl, R., Svejgaard, A., and Fugger, L. (1998) Definition of MHC and T cell receptor contacts in the HLA-DR4 restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 95, 7574-7569.
22. Holm, L., Kjellen, P., Holmdahl, R., and Kihlberg, J. (2005) Identification of the minimal glycopeptide core recognized by T cells in a model for rheumatoid arthritis. Bioorg. Med. Chem. 13, 473-482.
23. Landsteiner, K., and Jacobs, J. (1936) Studies on the sensitization of animals with simple chemical compounds. J. Exp. Med. 64, 629-639.
24. 1H NMR determination of the ionization constant of a carboxylic acid group of a haem protein in mixed aqueous-organic solvents using the Super-WEFT sequence. Magn. Reson. Chem. 29, 1036-1039.
25. Broddefalk, J., Bäckhand, J., Almqvist, F., Johansson, M., Holmdahl, R., and Kihlberg, J. (1998) T cells recognize a glycopeptide derived from type II collagen in a model for rheumatoid arthritis. J. Am. Chem. Soc. 120, 7676-7683.
26. Carpino, L. A., and Han, G. Y. (1972) The 9-fluorenylmethoxycarbonyl amino-protecting group. J. Org. Chem. 37, 3404-3409.
27. Scott, J. W., Parker, D., and Parrish, D. R. (1982) Improved syntheses of Nε-tert-butyloxycarbonyl-L-lysine and Nα-benzyloxycarbonyl-Nε- tert-butyloxycarbonyl-L-lysine. Synth. Commun. 11, 303-314.
28. White, J., Blackman, M., Bill, J., Kappler, J., Marrack, P., Gold, D. P., and Born, W. (1989) Two better cell lines for making hybridomas expressing specific T-cell receptors. J. Immunol. 143, 1822-1825.
29. Michaelsson, E., Holmdahl, M., Engstrom, A., Burkhardt, H., Scheynius, A., and Holmdahl, R. (1995) Macrophages, but not dendritic cells, present collagen to T-cells. Eur. J. Immunol. 25, 2234-2241.
30. Holm, L., Frech, K., Dzhambazov, B., Holmdahl, R., Kihlberg, J., and Linusson, A. (2007) Quantitative structure-activity relationship of peptides binding to the class II major histocompatibility complex molecule A(q) associated with autoimmune arthritis. J. Med. Chem. 50, 2049-2059.
31. Ahlfors, S. R., Sterner, O., and Hansson, C. (2003) Reactivity of contact allergenic haptens to amino acid residues in a model carrier peptide, and characterization of formed peptide-hapten adducts. Skin Pharm. Appl. Skin Phys. 16, 59-68.
32. Ahlfors, S. R., Kristiansson, M. H., Lindh, C. H., Jönsson, B. A. G., and Hansson, C. (2005) Adducts between nucleophilic amino acids and hexahydrophthalic anhydride, a structure inducing both types I and IV allergy. Biomarkers 10, 321-335.
33. Martin, S., Ortmann, B., Pflugfelder, U., Birsner, U., and Weltzien, H. U. (1992) Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides. J. Immunol. 149, 2569-2575.
34. Weltzien, H. U. (1995) How T cells recognize haptens. Am. J. Contact Dermatitis 6, 176-180.
35. + Tc1 cells is associated with the murine immune response to the contact sensitizer trinitrophenyl. Exp. Dermatol. 12, 78-85.
36. Dzhambazov, B., Holmdahl, M., Yamada, H., Lu, S., Vestberg, M., Holm, B., Johnell, O., Kihlberg, J., and Holmdahl, R. (2005) The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans. Eur. J. Immunol. 35, 357-366.
37. Holmdahl, M., Grubb, A., and Holmdahl, R. (2004) Cysteine proteases in Langerhans cells limits presentation of cartilage derived type II collagen for autoreactive T cells. Int. Immunol. 16, 717-726.